(Total Views: 378)
Posted On: 08/27/2022 10:48:33 AM
Post# of 36568
Agreed. I am just going by the bankruptcy and Generex owes both NGIO 5 million and Olaregen 9 million but has 330 million in NGIO and 18 mlllion in Olaragen.
So, they have payments they owe them or whatever, but the docs say they have value in them. So, even taking the debts away, they still have value unless the debts impact this in anyway.
What I am curious about is what is Olaragen currently doing. Are they selling anything? What is going on with their so called deals they had with a NY hospital, with other countries, etc.. Those were supposed to be worth millions alone, so where are the profits, etc.. That should be filtering to Generex as well.
What is going on with NGIO. If GNBT has a value of 330 million in NGIO due to an appraisal, then what are they doing about that value? Are they looking at what they can do with NGIO? The technology? The cancer drug? What's going on there?
There is a lot of potential. So between those two, there seems to be huge value, so where is it al?
So, they have payments they owe them or whatever, but the docs say they have value in them. So, even taking the debts away, they still have value unless the debts impact this in anyway.
What I am curious about is what is Olaragen currently doing. Are they selling anything? What is going on with their so called deals they had with a NY hospital, with other countries, etc.. Those were supposed to be worth millions alone, so where are the profits, etc.. That should be filtering to Generex as well.
What is going on with NGIO. If GNBT has a value of 330 million in NGIO due to an appraisal, then what are they doing about that value? Are they looking at what they can do with NGIO? The technology? The cancer drug? What's going on there?
There is a lot of potential. So between those two, there seems to be huge value, so where is it al?
(1)
(0)
